Table 1.
Main demographic and laboratory characteristics of 69 chronic hepatitis C patients from Pernambuco/Brazil
| Characteristics | Total (n = 69) | |
| Gender (n, %) | ||
| Male | 28 | 40.60% |
| Female | 41 | 59.40% |
| Age (yr)1 | 57.5 | ± 11.9 |
| BMI (kg/m2)1 | 27.7 | ± 4.7 |
| AST (U/L)2 | 51.5 | (33.7-88) |
| ALT (U/L)2 | 54 | (32.6-106) |
| AST/ALT1 | 1.03 | ± 0.44 |
| GGT (U/L)2 | 81.8 | (46.5-155) |
| Platelets (109/mm3)1 | 191 | ± 78 |
| Albumin (g/dL)1 | 4.08 | ± 0.56 |
| Total bilirubin (mg/dL)2 | 0.7 | (0.50-1.09) |
| Alkaline phosphatase (U/L)1 | 94.6 | ± 49.2 |
| INR1 | 1.09 | ± 0.14 |
| APRI2 | 0.8 | (0.44-2.18) |
| FIB-42 | 2.18 | (1.29-4.72) |
| Liver fragment length (cm)2 | 1.5 | (1.30-1.80) |
| Number of portal tracts2 | 15 | (12.0-20.0) |
| Stage of fibrosis (n, %) | ||
| F0 | 2 | 2.90% |
| F1 | 25 | 36.20% |
| F2 | 14 | 20.30% |
| F3 | 10 | 14.50% |
| F4 | 18 | 26.10% |
1
Mean ± standard deviation;
2
Median (P25-P75). ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; BMI: Body mass index; GGT: Gamma glutamyl transferase; INR: International normalized ratio; APRI: Aspartate aminotransferase to platelet ratio index; FIB-4: Fibrosis index based on four factors.